Does the New Fall- and Fracture Prevention Initiative in Oslo Have Effect?
NCT ID: NCT05680714
Last Updated: 2023-01-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
121000 participants
OBSERVATIONAL
2012-01-01
2024-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions the study aims to answer are whether this preventive initiative with improved care coordination reduces risk of subsequent hip fractures, admittance to nursing homes or death.
Researchers will compare two boroughs in Oslo who implemented the new patient pathway with the 13 other boroughs who did not reorganize their follow-up, but continued their care as usual.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of a Fall Prevention Program on Falls, Patient Safety Culture and Patient-perceived Safety
NCT03354468
Falls Prevention in Older Home Care Recipients
NCT02374307
Preventing Falls and Disability in Older Adults After Hip Fracture
NCT00795028
Fall Prevention Among Community Living Elderly
NCT01705912
Falling Risks in Elderly Adults : a Prospective Cohort Study
NCT03361059
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The intervention were introduced to the boroughs of Nordstrand and Østensjø, which are compared to the other 13 boroughs of Oslo in this controlled before and after study.
THE COHORT
All persons 65 years and older in Oslo are included in Oslo Fall Cohort and we follow all cohort participants prospectively.
OUTCOME VARIABLES
* Hip fracture
* Long term admittance to nursing home
* Death
TIMELINE
The investigators have defined the following dates as the start of intervention:
1. Start of intervention in Nordstrand borough is set to January 1, 2015.
2. Start of intervention Østensjø borough is set to September 1, 2016.
In the main analysis, fallers from the two intervention boroughs, Nordstrand and Østensjø, will be compared with fallers from the control boroughs during the intervention. Any differences between the intervention and control boroughs before the intervention started will be taken into account.
Data on all participants are available from 2010, and the participants will be followed from January 2012 until December 2019.
For each analysis, persons with a hip fracture or living in a nursing home at baseline will be excluded.
The analysis in the evaluation is based on registry data and no analysis relating the intervention to the outcomes has been done before registration in clinicaltrials.gov.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
FALLERS IN THE INTERVENTION BOROUGHS
Fallers 65+ years from the borough of Nordstrand from January 1. 2015 Fallers 65+ years from the borough of Østensjø from September 1. 2016
Fall injury will be included as a time-varying exposure variable. The individuals are all registered as non-fallers until they are registered with a fall injury in the NPR database, when they shift status to fallers.
Implement coordination of care with multifactorial falls- and fracture risk assessment and tailored intervention
FALLERS IN THE CONTROL BOROUGHS
Fallers 65+ years from all the 13 other boroughs of Oslo.
Fall injury will be included as a time-varying exposure variable. The individuals are all registered as non-fallers until they are registered with a fall injury in the NPR database, when they shift status to fallers.
No interventions assigned to this group
NON-FALLERS
All non-fallers 65+ years from all Oslo boroughs.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Implement coordination of care with multifactorial falls- and fracture risk assessment and tailored intervention
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Living on Oslo, Norway in the period January 1. 2012 - December 31. 2019
Exclusion Criteria
* Living in nursing home at baseline
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Oslo
OTHER
Oslo University Hospital
OTHER
Oslo Municipality
OTHER_GOV
Norwegian Institute of Public Health
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Haakon Eduard Meyer
Principal Investigator, Senior Medical Officer, Professor in Epidemiology and Preventive Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gro Idland, PhD
Role: STUDY_DIRECTOR
Municipality of Oslo, Department of Health
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
296587
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
RCN296587
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.